Best Practice Advances in Front-Line Management to Optimize Clinical Outcomes in
NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE LEARN MORE >Biomarker-Directed Stratification, Evolving Therapies and Clinical Trials for
Relapsed/Refractory NodalTFH Cell Lymphoma
The Current and Evolving Role and Guidelines for the Dual Delta-Gamma PI3K Inhibitor Duvelisib
-Management in T2D
Pivotal Advantages in Patient Engagement and
Improved Glycemic Metrics
Prompt Intervention, QoL Improvement, Rapid Culture Conversion, and Guidelines-Based Antimicrobial Therapy
Prompt Intervention, Individualized Treatment Goals, Regimen Adherence, and Guidelines-Based Assessments and Antimicrobial Therapy
Practical Action Steps for Establishing CGM-Based Care at the Front Lines of NP Practice
Precise, Individualized Sensor-Based Glucose Monitoring to Optimize Health Outcomes in Persons with Diabetes
A Managed Care-Focused Roadmap For Authorizing, Coding, and Deploying CGM Across the Spectrum of Diabetes Care
New Approaches for Minimizing Exacerbations Through DPP-1 Inhibition
A Practical Roadmap for Improving Patient Satisfaction, Motor Symptoms,
Clinical Outcomes, and ON/OFF Time in Persons with PD
FEATURED PROGRAMS
